Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Zifo Accelerates LIMS Master Data Validation with New AI-Enabled Services Accelerator

Zifo Logo

News provided by

Zifo

Aug 26, 2026, 09:00 ET

Share this article

Share toX

Share this article

Share toX

The new solution reduces master data review cycles from weeks to hours through automated cross-referencing, calculation verification, and real-time compliance checking.

CAMBRIDGE, Mass. and CAMBRIDGE, England, Aug. 26, 2026 /PRNewswire/ -- Zifo, a leading global enabler of AI and data-driven enterprise informatics for science-driven organizations, today announced the launch of its new AI-enabled services accelerator designed to transform Laboratory Information Management System (LIMS) master data validation.

In traditional LIMS deployments, validating calculations and complex Data File Definitions (DFDs) across multiple documents is a highly manual, labor-intensive process that can take potentially take weeks. Ensuring parameter names are correct and checking formula accuracy against pharmacopoeia standards requires deep LIMS expertise, and iterative dual-review cycles frequently create project bottlenecks. Furthermore, semantic inconsistencies and calculation syntax errors are often discovered late in testing, leading to costly rework.

Customer Challenges and How Zifo's Services Accelerator Helps 

Customer Challenge 


Solution

Manual Cross-Referencing: Validating 

calculations across multiple documents 

takes days. 


Automated Extraction: AI automatically extracts 

and validates formulas from DFD files, cross-

referencing against method specifications in 

minutes. 

Pharmacopoeia Verification: Checking 

formula correctness against standards is 

highly time-consuming. 


Regulatory Alignment: The LLM compares 

calculations to USP/Ph. Eur. standards and flags 

discrepancies with specific citations. 

Parameter References: Ensuring correct 

parameter naming requires deep LIMS 

expertise. 


Automated Checks: Validates that parameter 

names and Parameter List IDs used in calculations 

exactly match defined parameters. 

Syntax Errors: Calculation syntax 

errors are often discovered late in testing. 


Real-Time Validation: Identifies notation and 

embedded Groovy code errors during creation to 

prevent execution failures. 

Semantic Inconsistencies: Logic 

mismatches between DFDs and method 

specs are hard to detect. 


Contextual Analysis: Verifies that calculation 

logic aligns with method specification narratives 

(e.g., dilution factor consistency). 

Review Bottlenecks: Iterative dual 

review cycles (Zifo + Customer) create 

project delays. 


Streaming Results: Delivers real-time validation 

results to enable parallel reviews, reducing round-

trip iterations by 60%. 

LIMS implementations and master data creation are frequently constrained by the immense volume and complexity of data validation. Zifo's new AI-enabled services accelerator addresses this challenge by transforming a manual, weeks-long review cycle into a streamlined, real-time process that takes just hours. This will drastically accelerate go-live timelines for clients while ensuring strict regulatory compliance, audit readiness, and calculation accuracy.

Key capabilities of the newly launched services accelerator include:

  • Multi-Document Cross-Referencing: Performs semantic cross-referencing across DFD calculations, method specification narratives, and pharmacopoeia formulas to detect contextual inconsistencies (such as dilution factor logic) that simple logic checks often miss.
  • Real-Time Streaming Validation: Utilizes Server-Sent Events (SSE) to stream partial validation results instantly, allowing review teams to begin their analysis immediately rather than waiting for batch processing. This reduces round-trip iterations by up to 60%.
  • Citation-Backed Findings: Every validation finding includes specific citations from source documents (e.g., "Method Spec Section 7.3.2"), ensuring quality and compliance teams can quickly and confidently verify the AI's reasoning.
  • Pharmacopoeia Formula Matching: Automatically compares calculations against standard USP/Ph. Eur. formulas when not explicitly defined in the method specs, immediately flagging any deviations with regulatory implications.
  • Automated Syntax and Parameter Verification: Identifies embedded Groovy code errors and notation mistakes during creation to prevent execution failures, while validating that parameter names and Parameter List IDs exactly match defined parameters.
  • Custom Prompt Management: Allows flexible, session-level configurations to accommodate different validation rules for various project types—from strict drug substance compliance to flexible in-house methods—without requiring code changes.

Operating specifically within the Quality Control & Laboratory Informatics segment, the services accelerator delivers measurable impact across the LIMS value chain.

Powered by a robust technical architecture that includes an AI agent and custom document extractors, the services accelerator seamlessly handles diverse PDF method specifications and structured data formats, laying the foundation for future enhancements like automated test data generation and collaborative dual-review workflows.

Bridging Science and Technology Across the Value Chain

This AI-powered master data validation services accelerator is just one piece of a much larger puzzle. For science-driven organizations, persistent bottlenecks can easily drag down progress. Zifo solves this. Drawing on deep expertise as a global enabler of data-driven enterprise informatics, we bring domain-aware intelligence directly to the scientific value chain. By combining automated verification, real-time compliance alignment, and intelligent orchestration, we ensure that actionable, high-quality data is seamlessly integrated -- and actively maintained -- across the entire scientific value chain. https://zifo.com/practical-ai-blueprints/

About Zifo 

Zifo is the leading global enabler of AI and data-driven enterprise informatics for science-driven organizations. With extensive solutions and services expertise spanning research, development, manufacturing, and clinical domains, we serve a diverse range of industries, including Pharma, Biotech, Chemicals, Food and Beverage, Oil & Gas, and FMCG. Trusted by over 190 science-focused organizations worldwide, Zifo is the partner of choice for advancing digital scientific innovation.

For more information, please visit: https://zifo.com/

SOURCE Zifo

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Zifo Open Quiz 2026 Draws Over 1,200 Quizzers on Independence Day

Zifo Open Quiz 2026 Draws Over 1,200 Quizzers on Independence Day

Zifo, a leading global enabler of AI and data-driven enterprise informatics for science-driven organizations, successfully hosted the 35th annual...

A New Biopharma Roadmap: Zifo's SiEE Basel Event Puts Data Before AI Hype

A New Biopharma Roadmap: Zifo's SiEE Basel Event Puts Data Before AI Hype

Zifo's 2026 Scientific Informatics Experience Exchange (SiEE) in Basel convened leading experts from companies such as Roche, Bayer, Novo Nordisk,...

More Releases From This Source

Explore

Data Analytics

Data Analytics

Data Analytics

Data Analytics

Artificial Intelligence

Artificial Intelligence

The Latest Artificial Intelligence News

The Latest Artificial Intelligence News

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.